Involvement of c-Jun N-terminal kinase in oxidative stress-mediated suppression of insulin gene expression - PubMed (original) (raw)
. 2002 Aug 16;277(33):30010-8.
doi: 10.1074/jbc.M202066200. Epub 2002 May 14.
Affiliations
- PMID: 12011047
- DOI: 10.1074/jbc.M202066200
Free article
Involvement of c-Jun N-terminal kinase in oxidative stress-mediated suppression of insulin gene expression
Hideaki Kaneto et al. J Biol Chem. 2002.
Free article
Abstract
Oxidative stress, which is found in pancreatic beta-cells in the diabetic state, suppresses insulin gene transcription and secretion, but the signaling pathways involved in the beta-cell dysfunction induced by oxidative stress remain unknown. In this study, subjecting rat islets to oxidative stress activates JNK, p38 MAPK, and protein kinase C, preceding the decrease of insulin gene expression. Adenovirus-mediated overexpression of dominant-negative type (DN) JNK, but not the p38 MAPK inhibitor SB203580 nor the protein kinase C inhibitor GF109203X, protected insulin gene expression and secretion from oxidative stress. Moreover, wild type JNK overexpression suppressed both insulin gene expression and secretion. These results were correlated with changes in the binding of the important transcription factor PDX-1 to the insulin promoter; adenoviral overexpression of DN-JNK preserved PDX-1 DNA binding activity in the face of oxidative stress, whereas wild type JNK overexpression decreased PDX-1 DNA binding activity. Furthermore, to examine whether suppression of the JNK pathway can protect beta-cells from the toxic effects of hyperglycemia, rat islets were infected with DN-JNK expressing adenovirus or control adenovirus and transplanted under renal capsules of streptozotocin-induced diabetic nude mice. In mice receiving DN-JNK overexpressing islets, insulin gene expression in islet grafts was preserved, and hyperglycemia was ameliorated compared with control mice. In conclusion, activation of JNK is involved in the reduction of insulin gene expression by oxidative stress, and suppression of the JNK pathway protects beta-cells from oxidative stress.
Similar articles
- Role of oxidative stress in pancreatic beta-cell dysfunction.
Kajimoto Y, Kaneto H. Kajimoto Y, et al. Ann N Y Acad Sci. 2004 Apr;1011:168-76. doi: 10.1007/978-3-662-41088-2_17. Ann N Y Acad Sci. 2004. PMID: 15126294 - Role of JNK, p38, and ERK in platelet-derived growth factor-induced vascular proliferation, migration, and gene expression.
Zhan Y, Kim S, Izumi Y, Izumiya Y, Nakao T, Miyazaki H, Iwao H. Zhan Y, et al. Arterioscler Thromb Vasc Biol. 2003 May 1;23(5):795-801. doi: 10.1161/01.ATV.0000066132.32063.F2. Epub 2003 Mar 13. Arterioscler Thromb Vasc Biol. 2003. PMID: 12637337 - Parathyroid hormone-related protein induces insulin expression through activation of MAP kinase-specific phosphatase-1 that dephosphorylates c-Jun NH2-terminal kinase in pancreatic beta-cells.
Zhang B, Hosaka M, Sawada Y, Torii S, Mizutani S, Ogata M, Izumi T, Takeuchi T. Zhang B, et al. Diabetes. 2003 Nov;52(11):2720-30. doi: 10.2337/diabetes.52.11.2720. Diabetes. 2003. PMID: 14578290 - Oxidative stress and the JNK pathway as a potential therapeutic target for diabetes.
Kaneto H, Kawamori D, Nakatani Y, Gorogawa S, Matsuoka TA. Kaneto H, et al. Drug News Perspect. 2004 Sep;17(7):447-53. doi: 10.1358/dnp.2004.17.7.863704. Drug News Perspect. 2004. PMID: 15514704 Review. - Role of oxidative stress, endoplasmic reticulum stress, and c-Jun N-terminal kinase in pancreatic beta-cell dysfunction and insulin resistance.
Kaneto H, Nakatani Y, Kawamori D, Miyatsuka T, Matsuoka TA, Matsuhisa M, Yamasaki Y. Kaneto H, et al. Int J Biochem Cell Biol. 2005 Aug;37(8):1595-608. doi: 10.1016/j.biocel.2005.04.003. Epub 2005 Apr 22. Int J Biochem Cell Biol. 2005. PMID: 15878838 Review.
Cited by
- Pancreatic Crosstalk in the Disease Setting: Understanding the Impact of Exocrine Disease on Endocrine Function.
Villaca CBP, Mastracci TL. Villaca CBP, et al. Compr Physiol. 2024 Mar 29;14(2):5371-5387. doi: 10.1002/cphy.c230008. Compr Physiol. 2024. PMID: 39109973 Free PMC article. Review. - Exploring the globoid cell leukodystrophy protein network and therapeutic interventions.
Khanal P, Patil VS, Bhattacharya K, Shrivastava AK, Bhandare VV. Khanal P, et al. Sci Rep. 2024 Aug 5;14(1):18067. doi: 10.1038/s41598-024-66437-8. Sci Rep. 2024. PMID: 39103379 Free PMC article. - Pancreatic β-Cell Identity Change through the Lens of Single-Cell Omics Research.
Leenders F, de Koning EJP, Carlotti F. Leenders F, et al. Int J Mol Sci. 2024 Apr 26;25(9):4720. doi: 10.3390/ijms25094720. Int J Mol Sci. 2024. PMID: 38731945 Free PMC article. Review. - (+)-Catechin mitigates impairment in insulin secretion and beta cell damage in methylglyoxal-induced pancreatic beta cells.
Anaga N, Lekshmy K, Purushothaman J. Anaga N, et al. Mol Biol Rep. 2024 Mar 23;51(1):434. doi: 10.1007/s11033-024-09338-3. Mol Biol Rep. 2024. PMID: 38520585 - Unveiling the pathogenesis and therapeutic approaches for diabetic nephropathy: insights from panvascular diseases.
Zhang X, Zhang J, Ren Y, Sun R, Zhai X. Zhang X, et al. Front Endocrinol (Lausanne). 2024 Feb 22;15:1368481. doi: 10.3389/fendo.2024.1368481. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38455648 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous